首页|人参皂苷Rg3调控RANKL/RANK/TRAF6信号通路对绝经后骨质疏松症大鼠骨代谢、成骨细胞的影响

人参皂苷Rg3调控RANKL/RANK/TRAF6信号通路对绝经后骨质疏松症大鼠骨代谢、成骨细胞的影响

扫码查看
目的 分析人参皂苷Rg3调控核因子-κB受体活化体配体(RANKL)/核因子-κB受体活化体(RANK)/肿瘤坏死因子受体相关因子6(TRAF6)信号通路对绝经后骨质疏松症大鼠骨代谢、成骨细胞的影响。方法 选取50只健康雌性SPF级SD大鼠作为实验对象,随机取10只大鼠作为对照组,其余40只大鼠建立绝经后骨质疏松症模型,其中30只大鼠建模成功,将30只大鼠随机分为模型组、人参皂苷Rg3低剂量组、人参皂苷Rg3高剂量组,各10只。观察各组大鼠股骨病理组织,比较各组大鼠骨代谢指标、骨形态学指标、碱性磷酸酶(ALP)、甲状旁腺激素(PTH)、骨钙素、硬骨素水平,以及RANKL/RANK/TRAF6信号通路相关信使RNA(mRNA)及蛋白表达水平。结果 对照组大鼠骨小梁排列正常,成骨细胞、类骨质面积未发生变化,模型组大鼠成骨细胞数量减少。与模型组比较,人参皂苷Rg3低剂量组、人参皂苷Rg3高剂量组成骨细胞数量增多,且人参皂苷Rg3高剂量组成骨细胞数量比人参皂苷Rg3低剂量组多。各组大鼠骨小梁数量(TB。N)、骨小梁厚度(TB。Th)、总Ⅰ型胶原羧基端前肽(PⅠNP)、N-端骨钙素(N-MID)、PTH、骨钙素、硬骨素、RANKL mRNA、RANK mRNA、TRAF6 mRNA、RANKL蛋白、RANK蛋白、TRAF6蛋白水平比较,对照组>人参皂苷Rg3高剂量组>人参皂苷Rg3低剂量组>模型组,任意两组间比较,差异均有统计学意义(P<0。05)。各组大鼠骨小梁分离度(TB。Sp)、ALP水平比较,对照组<人参皂苷Rg3高剂量组<人参皂苷Rg3低剂量组<模型组,任意两组间比较,差异均有统计学意义(P<0。05)。结论 人参皂苷Rg3可改善骨代谢,提高骨钙素、硬骨素水平,使大鼠骨质疏松症得到改善,其作用机制可能与调控RANKL/RANK/TRAF6信号通路有关。
Effect of ginsenoside Rg3 regulating RANKL/RANK/TRAF6 signaling pathway on bone metabolism and osteoblast in postmenopausal osteoporosis rats
Objective To analyze the effect of ginsenoside Rg3 on regulating and nuclear factor-κB receptor activator ligand(RANKL)/nuclear factor-aB receptor activator(RANK)/tumor necrosis factor receptor-re-lated factor 6(TRAF6)signaling pathway on bone metabolism and osteoblast in postmenopausal osteoporosis rats.Methods Fifty healthy female SPF SD rats were selected as experimental objects,and 10 rats were ran-domly selected as control group,and the remaining 40 rats were established for postmenopausal osteoporosis model,of which 30 rats were successfully modelled,and 30 rats were randomly divided into model group,gin-senoside Rg3 low dose group and ginsenoside Rg3 high dose group,with 10 rats each.The pathological tissue of rats in each group was observed,and the levels of bone metabolism,bone morphology,alkaline phosphatase(ALP),parathyroid hormone(PTH),osteocalcin and osteosin,as well as messenger RNA(mRNA)and protein levels related to RANKL/RANK/TRAF6 signaling pathway were compared among all groups.Results In the control group,the bone trabecular arrangement was normal,and the area of osteoblasts and osteoid did not change,and the number of osteoblasts decreased in the model group.Compared with the model group,the number of osteoblasts in ginsenoside Rg3 low dose group and ginsenoside Rg3 high dose group increased,and the number of osteoblasts in ginsenoside Rg3 high dose group was more than that in ginsenoside Rg3 low dose group.Tra-becular quantity(TB.N),trabecular thickness(TB.Th),total type Ⅰ collagen carboxyl terminal propeptide(PⅠ NP),N-terminal osteocalcin(N-MID),PTH,osteocalcin,osteosin,RANKL mRNA,RANK mRNA,TRAF6 mRNA,RANKL protein,RANK protein and TRAF6 protein of rats in all groups were compared,the control group>ginsenoside Rg3 high dose group>ginsenoside Rg3 low dose group>model group,with statistical significance between any two groups(P<0.05).The trabecular separation(TB.Sp)and ALP level of rats in all groups were compared,the control group<ginsenoside Rg3 high dose group<ginsenoside Rg3 low dose group<model group,and the difference between any two groups was statistically significant(P<0.05).Conclusion Ginsenoside Rg3 can improve bone metabolism,increase the levels of osteocalcin and oste-osin and improve osteoporosis in rats.The mechanism may be related to the regulation of RANKL/RANK/TRAF6 signaling pathway.

osteoporosisginsenoside Rg3nuclear factor-κB receptor activator ligandnuclear fac-tor-KB receptor activatortumor necrosis factor receptor-related factor 6signaling pathwaybone me-tabolismosteoblast

费熙、殷静、张磊、范伟、李小平、唐光平

展开 >

湖北省武汉市中医医院骨伤科,湖北武汉 430000

湖北省武汉市武昌区妇幼保健院院感科,湖北武汉 430000

骨质疏松症 人参皂苷Rg3 核因子-κB受体活化体配体 核因子-κB受体活化体 肿瘤坏死因子受体相关因子6 信号通路 骨代谢 成骨细胞

2025

检验医学与临床
重庆市卫生信息中心 重庆市临床检验中心

检验医学与临床

影响因子:1.096
ISSN:1672-9455
年,卷(期):2025.22(1)